NGM Biopharmaceuticals Inc (NGM) will issue nearly 6.7 million shares between $14 and $16 each Thursday on the Nasdaq. The offering represents 10.3 percent of outstanding shares. The clinical-stage biotech company advances candidates for non-alcoholic steatohepatitis, reverse liver fibrosis and type 2 diabetes.
Silk Road Medical Inc (SILK) will issue nearly 4.7 million shares between $15 and $17 each Thursday on the Nasdaq. The offering represents 16.3 percent of outstanding shares. Based in California, the medtech company develops and manufactures proprietary transcarotid medical devices for carotid artery disease.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.